Word

I.Q.A.

Status

Dead

Status Code

402

Status Date

Sunday, June 10, 2018

Serial Number

79064112

Mark Type

3000

Filing Date

Tuesday, June 10, 2008

Abandoned Date

Sunday, June 10, 2018

Trademark Owner History

I.Q.A., a.s.

Classifications

5 Pharmaceutical preparations for the treatment of cancer, proliferative diseases, infectious diseases, hormonal diseases, immunity disorders, coagulation disorders, inflammatory diseases, skin diseases; bacterial, chemical, and biological preparations for medical and veterinary purposes,namely, for the treatment of cancer, proliferative diseases, infectious diseases, hormonal diseases,immunity disorders, coagulation disorders, inflammatory diseases, skin diseases; chemico-pharmaceutical preparations for the treatment of cancer, proliferative diseases, infectious diseases, hormonal diseases, immunity disorders, coagulation disorders, inflammatory diseases, skin diseases; herbal teas for medicinal purposes, medicinal herbs, drugs for medical purposes, namely, for the treatment of immunity disorders, skin disorders; diagnostic preparations for medical and veterinary purposes, frimigating preparations, namely, insecticides, pesticides, fungicides and herbicides; enzyme preparations, namely, improving inflammatory disorders; chemical preparations for analyzing DNA for medical purposes, bacteriological cultures media, vitamins for medical and veterinary purposes, antibiotics for the treatment of diseases caused by gram-positive and gram-negative pathogens; amino acids for medical purposes, analgesics, anesthetics, namely, for non-surgical use; cotton swabs for medical purposes, balms for medical purposes, albuminous foodstuffs specially adapted for medical purposes, diabetic sugar for medical purposes, suppositories for the treatment of pain; dietetic food and drinks adapted for medical use; hormones for medical purposes, capsules sold empty for medicines, first-aid boxes being first-aid kits, ointments for medical purposes for the treatment of skin disorders; adhesive plasters for topical application of drugs; isotopes, namely, radio-isotope markers for therapeutic or diagnostic use; super-oxidized water, radioactive substances, namely, diagnostic radio pharmaceutical preparations; radium, namely, as a component of radio-isotope markers for therapeutic or diagnostic use; esters, namely, as antihyperlipoproteinic drugs; tablets for the treatment of proliferative diseases, infectious diseases, hormonal diseases, immunity disorders, coagulation disorders, inflammatory diseases, skin diseases; hemoglobin, herbicides, anesthetics, namely, chloroform; antiseptic, namely, iodoform, medicated jujube for the treatment of skin disorders; blood plasma, lactose, for use as a dietary supplement; opiates for the treatment of sleep disturbances; purgatives; insecticides

42 Research and development in the field of pharmacy and medicine for others, research relating to healthcare, science and technology in the field of pharmacy, medicine, biotechnologies, chemistry; clinical, medical and scientific research, expert analysis in medicine, pharmacy, veterinary medicine, biological, bacteriological and chemical research, pharmaceutical testing; development and studies in the field(s) of chemistry, biochemistry, pharmacology, medicine, biotechnologies; quality control for others; medical physical, physical-chemical and chemical testing of medicines including tests relating to storing samples for faster, more sustainable, reliable studies; cosmetics research, expertise, namely, consultation and analysis concerning safety of used compounds; development of new technologies in the field(s) of chemistry analysis; scientific technical analysis; testing and measuring services relating to chemical and physical stability of drugs and chemical compounds, biosimilarity of drugs, bioequivalence of drugs; material testing, consultancy relating to biochemistry, development of computer hardware and software, medical laboratory research services; pharmaceutical discovery services, namely, pharmaceutical research; development of pharmaceutical compositions, chemical analysis, physics research, geological surveys, pharmaceutical clinical studies using web databases, design of computer systems and construction of Internet sites in the field of pharmacy; consultancy in the fields of computer applications and information technology; rental of software; installation, repair, maintenance and servicing of software; creation of interactive applications enabling the transfer and creation of graphic images using the Internet; software design, creation and maintenance of web pages for clients; hosting of web pages; installation of computer programs, computer system design, Internet database system and Internet application programming; updating and maintenance of computer programs, duplication of computer programs, technical studies in the field of computers and software; graphic arts designing; consultancy in the field of computer and information technology

Color is not claimed as a feature of the mark.
The mark consists of graphic elements in the form of five vertical bars of different lengths, followed by the word element "I.Q.A.".
The transliteration of the non-Latin characters in the mark is: I.Q.A.

Trademark Events

Mar 29, 2019

Undeliverable Mail - No Action Taken

Jan 11, 2019

Notification Of Effect Of Cancellation Of Intl Reg Mailed

Jan 10, 2019

Death Of International Registration

Feb 5, 2011

Final Decision Transaction Processed By Ib

Jan 14, 2011

Final Disposition Notice Sent To Ib

Jan 14, 2011

Final Disposition Notice Created, To Be Sent To Ib

Jul 23, 2010

Notification Of Possible Opposition - Processed By Ib

Jul 8, 2010

Notification Of Possible Opposition Sent To Ib

Jul 8, 2010

Notification Of Possible Opposition Created, To Be Sent To Ib

Jan 14, 2010

Abandonment Notice Mailed - Incomplete Response

Jan 14, 2010

Abandonment - Incomplete Response

Jun 12, 2009

Notice Of Unresponsive Amendment - Mailed

Jun 11, 2009

Report Unresponsive Amendment - Completed

May 12, 2009

Amendment From Applicant Entered

May 12, 2009

Correspondence Received In Law Office

May 11, 2009

Paper Received

Apr 10, 2009

Notice Of Unresponsive Amendment - Mailed

Apr 10, 2009

Report Unresponsive Amendment - Completed

Mar 24, 2009

Teas/Email Correspondence Entered

Mar 24, 2009

Correspondence Received In Law Office

Mar 24, 2009

Teas Response To Office Action Received

Mar 18, 2009

Amendment From Applicant Entered

Mar 18, 2009

Correspondence Received In Law Office

Mar 16, 2009

Assigned To Lie

Mar 13, 2009

Fax Received

Mar 14, 2009

Refusal Processed By Ib

Feb 17, 2009

Non-Final Action Mailed - Refusal Sent To Ib

Feb 17, 2009

Refusal Processed By Mpu

Feb 14, 2009

Non-Final Action (Ib Refusal) Prepared For Review

Feb 13, 2009

Non-Final Action Written

Feb 10, 2009

Application Filing Receipt Mailed

Feb 6, 2009

Assigned To Examiner

Feb 6, 2009

New Application Office Supplied Data Entered In Tram

Feb 5, 2009

Sn Assigned For Sect 66a Appl From Ib